Close Menu

This article has been updated with a statement from Guardant Health.

NEW YORK (GenomeWeb) – Foundation Medicine has filed a lawsuit against Guardant Health, alleging that the company willfully infringes one of its recently awarded patents.

In the complaint, filed yesterday with the US District Court for the Eastern District of Texas, Marshall Division, Foundation Medicine claims that the Guardant360 cell-free tumor DNA liquid biopsy test infringes its US Patent No. 9,340,830.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.